Immunovant Inc
IMVT15.710USD
-0.370-2.30%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
2.67BMarket Cap
LossP/E TTM
Immunovant Inc
15.710
-0.370-2.30%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating expenses
40.73%113.83M
85.70%114.30M
87.29%115.74M
42.90%94.28M
25.86%80.88M
13.93%61.55M
24.56%61.80M
63.41%65.98M
36.06%64.26M
30.91%54.03M
31.78%49.61M
35.10%40.38M
63.32%47.23M
30.44%41.27M
79.51%37.65M
12.41%29.89M
41.18%28.92M
7437.69%31.64M
22613.39%20.97M
5907900.00%26.59M
--20.48M
--419.76K
--92.34K
--450.00
R&D expenses
41.78%93.65M
95.54%94.52M
102.82%97.27M
49.23%75.47M
27.43%66.06M
14.40%48.34M
27.08%47.96M
77.90%50.58M
62.06%51.84M
41.99%42.25M
76.67%37.74M
51.99%28.43M
71.83%31.99M
41.08%29.76M
78.37%21.36M
10.54%18.70M
31.39%18.61M
325.82%21.09M
--11.98M
--16.92M
--14.17M
--4.95M
----
----
Depreciation, depletion, and amortization
70.31%109.00K
70.69%99.00K
58.93%89.00K
50.94%80.00K
18.52%64.00K
18.37%58.00K
21.74%56.00K
20.45%53.00K
38.46%54.00K
48.48%49.00K
64.29%46.00K
69.23%44.00K
77.27%39.00K
73.68%33.00K
100.00%28.00K
160.00%26.00K
266.67%22.00K
26.67%19.00K
--14.00K
--10.00K
--6.00K
--15.00K
----
----
Other operating expenses
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--395.16K
--67.74K
--450.00
Operating profit
-40.73%-113.83M
-85.70%-114.30M
-87.29%-115.74M
-42.90%-94.28M
-25.86%-80.88M
-13.93%-61.55M
-24.56%-61.80M
-63.41%-65.98M
-36.06%-64.26M
-30.91%-54.03M
-31.78%-49.61M
-35.10%-40.38M
-63.32%-47.23M
-30.44%-41.27M
-79.51%-37.65M
-12.41%-29.89M
-41.18%-28.92M
-7437.69%-31.64M
-22613.39%-20.97M
-5907900.00%-26.59M
---20.48M
---419.76K
---92.34K
---450.00
Net non-operating interest income (expenses)
Non-operating interest income
-17.79%6.89M
-48.62%4.59M
70.02%6.07M
76.63%7.18M
140.78%8.38M
203.43%8.93M
209.53%3.57M
--4.07M
--3.48M
--2.94M
--1.15M
----
----
----
----
----
----
----
----
----
----
--683.14K
--341.56K
----
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
--0.00
----
--0.00
--376.00K
----
----
Special income (expenses)
--0.00
--0.00
--0.00
100.00%0.00
--0.00
100.00%0.00
--0.00
---12.50M
--0.00
---10.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
141.40%1.07M
-214.99%-1.26M
3045.00%629.00K
-93.97%28.00K
-826.69%-2.59M
162.27%1.09M
-97.48%20.00K
31.07%464.00K
709.09%356.00K
-1441.23%-1.76M
1044.05%793.00K
156.55%354.00K
-93.53%44.00K
77.34%-114.00K
-137.33%-84.00K
-745.95%-626.00K
635.43%680.00K
-327.60%-503.00K
--225.00K
---74.00K
---127.00K
--221.00K
----
----
Income before tax
-40.99%-105.87M
-115.37%-110.97M
-87.33%-109.04M
-17.75%-87.07M
-24.27%-75.09M
18.00%-51.53M
-22.11%-58.21M
-84.77%-73.95M
-28.06%-60.42M
-51.84%-62.84M
-26.32%-47.67M
-31.16%-40.02M
-67.10%-47.18M
-28.75%-41.38M
-81.86%-37.73M
-14.45%-30.51M
-37.01%-28.24M
-12303.90%-32.14M
-8425.71%-20.75M
-5924344.44%-26.66M
---20.61M
--263.38K
--249.22K
---450.00
Income tax
151.29%583.00K
240.74%152.00K
-82.82%78.00K
800.00%77.00K
123.41%232.00K
-127.91%-108.00K
73.95%454.00K
-103.13%-11.00K
-8158.33%-991.00K
--387.00K
941.94%261.00K
958.54%352.00K
84.81%-12.00K
100.00%0.00
-177.50%-31.00K
-185.42%-41.00K
-33.90%-79.00K
-365.38%-367.00K
-39.82%40.00K
--48.00K
---59.00K
--138.29K
--66.47K
----
Income after tax
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-26.73%-75.32M
18.68%-51.42M
-22.40%-58.66M
-83.13%-73.94M
-25.99%-59.43M
-52.78%-63.23M
-27.12%-47.93M
-32.50%-40.37M
-67.52%-47.17M
-30.24%-41.38M
-81.36%-37.70M
-14.09%-30.47M
-37.02%-28.16M
-25502.51%-31.78M
-11475.71%-20.79M
-5935011.11%-26.71M
---20.55M
--125.09K
--182.75K
---450.00
Net income from continuous operations
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-26.73%-75.32M
18.68%-51.42M
-22.40%-58.66M
-83.13%-73.94M
-25.99%-59.43M
-52.78%-63.23M
-27.12%-47.93M
-32.50%-40.37M
-67.52%-47.17M
-30.24%-41.38M
-81.36%-37.70M
-14.09%-30.47M
-37.02%-28.16M
-25502.51%-31.78M
-11475.71%-20.79M
-5935011.11%-26.71M
---20.55M
--125.09K
--182.75K
---450.00
Net income attributable to controlling interests
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-26.73%-75.32M
18.68%-51.42M
-22.40%-58.66M
-83.13%-73.94M
-25.99%-59.43M
-52.78%-63.23M
-27.12%-47.93M
-32.50%-40.37M
-67.52%-47.17M
-30.24%-41.38M
-81.36%-37.70M
-14.09%-30.47M
-37.02%-28.16M
-25502.51%-31.78M
-11475.71%-20.79M
-5935011.11%-26.71M
---20.55M
--125.09K
--182.75K
---450.00
Net income attributable to common shareholders
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-26.73%-75.32M
18.68%-51.42M
-22.40%-58.66M
-83.13%-73.94M
-25.99%-59.43M
-52.78%-63.23M
-27.12%-47.93M
-32.50%-40.37M
-67.52%-47.17M
-30.24%-41.38M
-81.36%-37.70M
-14.09%-30.47M
-37.02%-28.16M
-25502.51%-31.78M
-11475.71%-20.79M
-5935011.11%-26.71M
---20.55M
--125.09K
--182.75K
---450.00
Basic earnings per share
-23.57%-0.64
-112.58%-0.76
-66.57%-0.74
-5.30%-0.60
-13.36%-0.52
27.65%-0.36
-8.79%-0.45
-63.56%-0.57
-12.52%-0.46
-36.68%-0.49
-18.95%-0.41
-11.74%-0.35
-40.76%-0.41
-10.87%-0.36
-40.25%-0.35
17.80%-0.31
23.53%-0.29
-3830.00%-0.32
-2039.02%-0.25
-942725.00%-0.38
---0.38
--0.01
--0.01
--0.00
Diluted earnings per share
-23.57%-0.64
-112.58%-0.76
-66.57%-0.74
-5.30%-0.60
-13.36%-0.52
27.65%-0.36
-8.79%-0.45
-63.56%-0.57
-12.52%-0.46
-36.68%-0.49
-18.95%-0.41
-11.74%-0.35
-40.76%-0.41
-10.87%-0.36
-40.25%-0.35
17.80%-0.31
23.53%-0.29
-3830.00%-0.32
-2039.02%-0.25
-942725.00%-0.38
---0.38
--0.01
--0.01
--0.00
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
